Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes
Recruiting in Palo Alto (17 mi)
+195 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 3
Waitlist Available
Sponsor: Bristol-Myers Squibb
No Placebo Group
Pivotal Trial (Near Approval)
Prior Safety Data
Trial Summary
What is the purpose of this trial?
The purpose of this study is to compare Muraglitazar and Pioglitazone in patients with Type 2 Diabetes. Both the safety and blood sugar lowering effects of these treatments will be studied.
Research Team
Eligibility Criteria
Inclusion Criteria
Type 2 Diabetes
HbA1c > = 8.0% and < = 12.0%
Serum triglyceride concentration < = 600 mg/dL
See 3 more
Treatment Details
Interventions
- Muraglitazar (Thiazolidinedione)
- Pioglitazone (Thiazolidinedione)
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Local InstitutionBoynton Beach, FL
Local InstitutionChipley, FL
Local InstitutionCherry Hill, NJ
Local InstitutionMount Pleasant, SC
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Bristol-Myers Squibb
Lead Sponsor
Trials
2731
Patients Recruited
4,127,000+
Headquarters
New York City, USA
Known For
Oncology & Cardiovascular
Top Products
Eliquis, Opdivo, Revlimid, Orencia
Merck Sharp & Dohme LLC
Industry Sponsor
Trials
4096
Patients Recruited
5,232,000+